Taylor et al v. Bristol-Myers Squibb Company, Inc. et al
| David Taylor and Leatha Taylor |
| Bristol-Myers Squibb Company, Inc. and AstraZeneca Pharmaceuticals LP |
| 5:2018cv00053 |
| February 12, 2018 |
| US District Court for the Eastern District of Kentucky |
| Lexington Office |
| Powell |
| Karen K. Caldwell |
| Personal Injury: Health Care |
| 28 U.S.C. ยง 1332 |
| Both |
Follow case documents by RSS
Available Case Documents
The following documents for this case are available for you to view or download:
| Document Text |
|---|
Filing
362
OPINION AND ORDER: 1) the plaintiffs' Rule 59 motion (776 in 5:18-2809) to alter or amend the Court's Opinion and Order entered August 2, 2022 is DENIED; and 2) the defendants' motion (780 in 5:18-2809) to direct the clerk to enter final judgment pursuant to Rule 58 is GRANTED to the extent that it requests the Court to enter a final judgment in this matter. Signed by Judge Karen K. Caldwell on 11/3/2022. Associated Cases: 5:18-md-02809-KKC-MAS et al.(STC)cc: COR
|
|
Filing
352
OPINION & ORDER ON DEFENDANTS' MOTION FOR SUMMARY JUDGMENT (DE 746 ) AND PLAINTIFFS' MOTION TO MODIFYING SCHEDULING ORDER (DE 748 ) AND TO FILE A SUPPLEMENTAL BRIEF (DE 757 ) :1. Defendants' 746 motion for summary judgment is GRAN TED; 2. Plaintiffs' 748 motion to modify the scheduling order and to stay ruling on this motion for summary judgment is DENIED; 3. Plaintiffs' 630 motion to exclude the testimony of Dr. Michael Fowler is DENIED as moot; 4. Plaintiffs� 39; 757 motion for leave to file supplemental response brief is GRANTED and the Clerk of court SHALL FILE in the record the tendered supplemental response brief (DE 757 -2) and the tendered supplemental reply brief (DE 760 -1); 5. Plaintiffs 9; motion for hearing is DENIED, the Court finding that the partieshave more than adequately briefed the motions currently before the Court and that a hearing is not necessary; and 6. Within 21 days of the entry of this Opinion & Order, defendants SH ALL FILE in this MDL Master File 5:18-2809 a list of all open cases that name defendants other than AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb Company, and McKesson Corporation (the defendants who moved for summary judgment).. Signed by Judge Karen K. Caldwell on 8/2/2022.Associated Cases: 5:18-md-02809-KKC-MAS et al.(KM)cc: COR
|
|
Filing
332
OPINION AND ORDER ON MOTION TO EXCLUDE EXPERTS (DE 626, 630, 633, 635): 1. The defendant's motion to exclude testimony of Dr. Parag Goyal 636 is GRANTED; 2. The plaintiff's motion to excluded the testimony of Dr. Suneil Koliwad 630 is DENIED; 3. The plaintiff's motion to exclude testimony of Dr. Eric Adler 633 is DENIED; 4. The plaintiff's motion to exclude the testimony of Dr. Todd Lee 635 is DENIED. Signed by Judge Karen K. Caldwell on 1/5/2022.Associated Cases: 5:18-md-02809-KKC-MAS et al.(KM)cc: COR
|
|
Filing
202
MEMORANDUM OPINION & ORDER: 1) Plas Motion to Compel and for Sanctions (DE 479 ) is GRANTED IN PART as following: a) Redactions of date of death and treatment duration to Exhibits 11, 12, and 13 of Motion and Exhibit 3 to Reply where those dates are expressed as a number of days rather than a calendar date; b) Redactions for "nonresponsiveness" to Exhibit 14 that are part of email chain entitled "June 16, 2014 Email from Krisztina Debreczeni to Rachpal Malhotra, et al. "; c) Exhibits 9 of Motion and Exhibits 6, 7, 8, 9, and 10 to Reply, to extent these are publicly available documents; 2) Plas Motion to Compel and for Sanctions (DE 479 ) is DENIED IN PART as following: a) Redactions of pharmocovig ilance information not related to heart failure and/or increased risk of adverse cardiac events; b) Redaction of OneNote files due to "nonresponsiveness"; and c) The request for sanctions. Within 14 days either party may appeal this decision to Judge Caldwell pursuant § 636(b)(1)(A) and FRCP 72(a). Signed by Magistrate Judge Matthew A. Stinnett on 8/19/2020. Associated Cases: 5:18-md-02809-KKC-MAS et al. (TDA) cc: COR
|
|
Filing
184
MEMORANDUM OPINION AND ORDER: (1) Defendants' Motion for Supplemental Protective Order 434 is DENIED; (2) Plaintiff's Motion for Sanctions 456 is DENIED; and The undersigned enters this Memorandum Opinion pursuant to 28 U.S.C. § 6 36(b) (1)(A). Within fourteen (14) days after being served with a copy of this Memorandum Opinion, either party may appeal this decision to Judge Caldwell pursuant § 636(b)(1)(A) and FED. R. CIV. P. 72(a). Signed by Magistrate Judge Matthew A. Stinnett on 5/22/2020. Associated Cases: 5:18-md-02809-KKC-MAS et al.(CBD)cc: COR
|
|
Filing
145
MEMORANDUM OPINION & ORDER: For the reasons stated herein, IT IS ORDERED that Plaintiffs Motion to Compel 349 is: 1) GRANTED as to the clinical and non-clinical trial data; 2) GRANTED as to the pharmacoviligence data; 3) GRANTED IN PART and DENIED IN PART, as detailed above, as to the custodial files. Signed by Magistrate Judge Matthew A. Stinnett on 11/5/2019.Associated Cases: 5:18-md-02809-KKC-MAS et al.(CBD)cc: COR
|
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Kentucky Eastern District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
